Maynard Um
-
-
-
-
-
-
-
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
-
-
-
-
-
-
-
InMed Announces Results of 2024 Annual General Meeting
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Granted Nasdaq Exception to Implement Share Consolidation
-
-
-
-
-
-
-
InMed (INM) Receives NASDAQ Delisting Notice
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

